HRTX
Heron Therapeutics, Inc.
stockNASDAQ
Market OpenNov 9, 2026 10:46:09 AM EST
0.38USD+29.181%(+0.09)116,072,104
Pre-marketNov 9, 2026 9:29:30 AM EST
0.372USD+26.962%(+0.079)
Loading…
Loading…
71.40M
Healthcare
Biotechnology
CEO
Barry Quart
HQ
San Diego, CA, USA
145
Previous Close
$0.29
Beta
1.73
52-Week High
$1.58 2026-01-09
52-Week Low
$0.26 2026-09-21
SMA 50
$0.32
SMA 200
$0.67
Avg. Vol 10D
1.11M
Avg. Vol 30D
2.03M
Avg. Vol 90D
2.39M
Relative Vol
14.14
189.85M
146.51M
77.17%
36,741,075
25.08%
14.24
35%/65%
50.29%
34.37%
2.3200%
100,000
33,304
77,305
210,633
Nov 9, 2026 (today)
May 25, 2007 · 1-for-4 (reverse)
Nov 9, 2026
Heron Therapeutics Announces Third Quarter 2026 Financial Results · 
GlobeNewswire Inc.
HRTX Profile
heron therapeutics, inc. (formerly a.p. pharma, inc.) is a specialty pharmaceutical company developing products using its proprietary biochronomer™ polymer-based drug delivery platform. this drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that must be injected once or twice per day to products that need to be injected only once every one or two weeks.
HRTX Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 0.30 | 2026-11-02 | +27.45% | 1.688 |
| 1M | 0.41 | 2026-10-09 | -7.39% | 2.042 |
| 3M | 0.34 | 2026-08-10 | +12.27% | 1.730 |
| 6M | 1.21 | 2026-05-08 | -68.92% | 1.211 |
| 1Y | 1.11 | 2025-11-10 | -66.12% | 1.731 |
| 2Y | 1.75 | 2024-11-08 | -78.51% | — |
| 5Y | 12.41 | 2021-11-09 | -96.97% | 1.617 |
HRTX Stock Summary
Heron Therapeutics, Inc. (NASDAQ:HRTX) stock price today is $0.38, and today's volume is 28,668,407. HRTX is up 28.362% today. The 30 day average volume is 2.03M. HRTX market cap is $71.40M with 189.85M shares outstanding.